AMP has just published!
"Pigmentação Cutânea Secundária a Minociclina"
Letter to the Editor by Carolina Figueiredo and Maria Manuel Xavier from Departamento de Dermatologia do Centro Hospitalar e Universitário de Coimbra, Portugal.
Full paper available here:

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19894

#Hyperpigmentation #chemicallyinduced #Minocycline #adverseeffects

RT @BBI_Health@twitter.com

Adjunctive #minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response @PNIRS@twitter.com @ELSneuroscience@twitter.com @droliviadean@twitter.com @IMPACTDeakin@twitter.com #OpenAccess #inflammation #immunity #immunesystem
https://doi.org/10.1016/j.bbih.2022.100581

🐦🔗: https://twitter.com/BBI_Health/status/1613908205729611776

Excellent review of novel and emerging pharmacological and neuromodulatory treatments of depression in the Lancet:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02080-3/fulltext

#Psychiatry #MedMastodon #ketamine #rTMS #psychedelics #psilocybin #brexanolone #tDCS #deepbrainstimulation #minocycline

RT @BBI_Health@twitter.com

Sex differences in a double-blind randomized clinical trial with #minocycline in treatment-resistant depressed patients: #CRP and IL-6 as sex-specific predictors of treatment response #OpenAccess #TRD @SPILabKCL@twitter.com @PIXIELabKCL@twitter.com @Lombardo_GG@twitter.com @MondelliValeria@twitter.com

https://doi.org/10.1016/j.bbih.2022.100561

🐦🔗: https://twitter.com/BBI_Health/status/1597573237889990656